Drug Discovery, Designing Chemistry and Pharmaceutical Analysis

While ‘biobetters’ are meant to be an innovation in provision of aff ordable drugs to all those people engrossed in debilitating poverty, the challenge arises on how to navigate the complex regulatory frameworks, which fundamentally hamper access to the life-giving aff ordable medicines. Th is keynote address grapples with ways of navigating regulatory frameworks in Africa so as to make ‘biobetters’ easily available to the masses of people who are unhealthy but cannot aff ord the expensive life-giving medicines available in the market. Th e entry point of this keynote address is the ‘Right to Health’ and how this has remained an aspiration for the poor people of Africa. It proceeds to documents how the existing regulatory frameworks limits rather than enhance access to ‘biobetters’ in Africa. It ends with explorations of ways of democratizing the regulatory frameworks in such a way that they enable the realization of the ‘Right to Health’ in Africa—A continent where human life is still being lost due to curable diseases.